Category Archives: FDA


6 THINGS THE US GOVERNMENT CAN AND SHOULD DO TO STOP THE SPREAD OF ANTIBIOTIC RESISTANT SUPERBUGS

In my last post, I discussed seven things individual consumers can do to stop the spread of antibiotic resistant superbugs. I left out one important element: the need to lobby our government’s leaders to make this issue a priority. This summer, combating antibiotic resistance is making headlines on both the national and international level. On […]

Read More

Posted in FDA, Global Health, National Healthcare, Resources, WHO; Tagged: , , , .


On the Pseudo-Science of the Organic Food Movement

I should premise this entire post on food safety profiles of organic and genetically modified organisms (GMOs), by stating that you will find no heroes here nor any side to root for. Both the organic industry and the GMO industry have evolved substantial villains – some of whom are identifiable and some of whom are essentially […]

Read More

Posted in FDA; Tagged: , , .


7 things YOU can and SHOULD do to stop the spread of antibiotic resistant superbugs

 The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant. Here is a hypothetical illustration. Mr. X. has a sore throat. He buys some […]

Read More

Posted in FDA, Global Health, WHO; Tagged: , , , , .


Hey, Hey, FDA! What do we want? Better Sunscreen! When do we want it? Now!

5 Facts on Skin Cancer, Sunscreen and U.S. Pharmaceutical Policy On my walk to the O’Neill Institute yesterday, I was stopped by a group of L’Oréal representatives handing out free samples of their latest sunscreen products along with information on the PASS Coalition, a lobbying effort on the part of cosmetic manufacturers and other consumer […]

Read More

Posted in FDA; Tagged: , , , , , .


A nutritionist named Coca-Cola

This week, the Supreme Court heard arguments in a case brought by POM Wonderful  gainst Coca-Cola, alleging fraudulent and deceptive advertising of Coca-Cola’s Pomegranate-Blueberry juice. The legal question centered on whether a private party can bring a lawsuit for misleading advertising if a label is compliant with regulations established by a federal agency, here the […]

Read More

Posted in FDA, Global Health, National Healthcare, Resources; Tagged: , , , , , .


Innovative Solutions for Complex Health Challenges: Our Past, Present, and Future – The O’Neill Institute Retrospective

We are delighted to present the Retrospective for the O’Neill Institute for National and Global Health Law at Georgetown University, Innovative Solutions for Complex Health Challenges: Our Past, Present, and Future.  

Read More

Posted in FCTC, FDA, Global Health, Health reform, Human Rights, National Healthcare, Resources, Tobacco, Trade, WHO; Tagged: , , , , , , , , , , , , , .


US FDA Commissioner Margaret Hamburg to Keynote O’Neill Institute Summer Program on Emerging Issues in Food and Drug Law

The Commissioner of the United States Food and Drug Administration, Margaret Hamburg will provide the keynote address to the O’Neill Institute for National and Global Health Law’s Summer Program on Emerging Issues in Food and Drug Law. Margaret A. Hamburg became the 21st commissioner of food and drugs on May 18, 2009. The second woman […]

Read More

Posted in FDA, Global Health, National Healthcare, Tobacco, Trade, Uncategorized; Tagged: , , , , , .


July 14-18 – Emerging Issues in Food and Drug Law (O’Neill Institute Summer Program with Confirmed Speakers)

Please join the O’Neill Institute for National and Global Health Law at Georgetown University for a one-week intensive summer institute exploring the domestic and international legal, regulatory, and policy framework shaping the safety and availability of foods and medicines worldwide. The program will cover U.S. domestic law including recent laws and regulations; international regulatory harmonization […]

Read More

Posted in FDA, Global Health, Health reform, National Healthcare, Tobacco, Trade, Uncategorized; Tagged: , , , , .


Is obesity the ticket to fighting antibiotic resistance?

Research points to the possibility that taking antibiotics could lead to weight gain. Could this reality be the necessary catalyst to change the way we use antibiotics in general?Antibiotic overuse is a public health crisis. For decades, scientists have supported changing antibiotic prescribing practices in response to the alarming consequences of their overuse – most […]

Read More

Posted in FDA, Global Health, National Healthcare, Uncategorized; Tagged: , .


Do prescription drugs need a message?

The recent controversy surrounding a relatively new blood thinner called Pradaxa (dabigatran) centers not on the drug itself, but on the safety of the drug’s message. Brought to market as a superior product to the long-standing market leader, Coumadin (warfarin), Pradaxa is touted for its ability to treat atrial fibrillation without the inconvenience of frequent […]

Read More

Posted in FDA, National Healthcare;


Browse by Category

Browse by Month

2014

July (8), June (12), May (10), April (12), March (11), February (12), January (7)

2013

December (8), November (8), October (15), September (5), August (4), July (8), June (13), May (10), April (8), March (9), February (8), January (3)

2012

December (3), November (3), October (2), August (1), July (6), June (2), May (3), April (3), March (2), February (2), January (4)

2011

December (2), November (2), October (4), September (3), August (5), July (5), June (9)

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.